Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Neurones (NRO) Stock Price & Analysis

NRO Stock Chart & Stats

€38.05€0.05(0.13%)
At close: 5:30 PM GMT+1
EUR 35EUR 37.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 37.95 - EUR 38.45
52-Week Range
EUR 31.90 - EUR 45.00
Previous Close
EUR 38.00
Volume
4,245
Average Volume (3M)
6,656
Market Cap
EUR 907.21M
Enterprise Value
EUR 631.41M
Total Cash (Recent Filing)
EUR 301.88M
Total Debt (Recent Filing)
EUR 41.30M
Price to Earnings (P/E)
16.7
Beta
0.38
Next Earnings
Mar 10, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jun 10, 2026
Dividend Yield
3.68%

Bulls Say, Bears Say

Bulls Say

Steady Revenue And Profitability

Sustained revenue expansion alongside resilient EBIT margins indicates durable client demand and operating discipline. This supports the business model’s ability to grow while remaining consistently profitable across changing project and service mixes.

Low Leverage And Improving Returns

Very low leverage limits financial risk and preserves flexibility for investment or shareholder returns. Rising ROE also shows improving capital efficiency, strengthening Neurones’ ability to compound value without relying heavily on debt.

Healthy Operating Cash Generation

Reliable operating cash generation and generally strong earnings conversion provide funding for growth, dividends, and investment. This reduces dependence on external financing, although periodic free-cash-flow swings remain a limitation.

Bears Say

Gross-Margin Volatility

Large gross-margin fluctuations make the underlying economics of projects and service contracts less predictable. They may reflect changes in cost mix or classification, complicating assessment of sustainable profitability and limiting forecasting confidence.

Uneven Free-Cash-Flow Growth

Recurring periods of declining free cash flow suggest working-capital requirements or reinvestment can materially affect cash conversion. This reduces predictability of funds available for dividends, acquisitions, or other long-term priorities.

Declining EPS Growth

Negative EPS growth indicates that recent expansion has not translated into corresponding per-share earnings improvement. If this persists, it could signal pressure from staffing costs, project mix, or operating leverage and weaken the pace of shareholder earnings growth.

Neurones News

NRO FAQ

What was Neurones’s price range in the past 12 months?
Neurones lowest stock price was €31.90 and its highest was €45.00 in the past 12 months.
What is Neurones’s market cap?
Neurones’s market cap is €907.21M.
When is Neurones’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Neurones’s earnings last quarter?
Neurones released its earnings results on Sep 09, 2026. The company reported €1.073 earnings per share for the quarter.
Is Neurones overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Neurones pay dividends?
Neurones pays a Annually dividend of €1.4 which represents an annual dividend yield of 3.68%. See more information on Neurones dividends here
What is Neurones’s EPS estimate?
Neurones’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neurones have?
Neurones has 23,842,455 shares outstanding.
What happened to Neurones’s price movement after its last earnings report?
Neurones reported an EPS of €1.073 in its last earnings report. Following the earnings report the stock price went down -0.701%.
Which hedge fund is a major shareholder of Neurones?
Currently, no hedge funds are holding shares in FR:NRO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology